Equities
Health CareMedical Equipment and Services
  • Price (USD)176.92
  • Today's Change0.32 / 0.18%
  • Shares traded436.52k
  • 1 Year change+25.56%
  • Beta0.4654
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

  • Revenue in USD (TTM)10.16bn
  • Net income in USD892.00m
  • Incorporated1996
  • Employees45.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DGX:NYQ since
announced
Transaction
value
University Hospitals Health System-Outreach Laboratory Services BusinessDeal completed21 Aug 202421 Aug 2024Deal completed17.24%--
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hims & Hers Health Inc1.78bn164.40m10.74bn1.64k70.1619.5357.486.020.68390.68397.402.462.667.73267.341,090,014.0024.54-3.9134.03-4.7477.04--9.21-2.351.32--0.00--69.33--635.28155.96----
Davita Inc12.97bn859.61m10.76bn76.00k14.11--5.690.8310.1010.10152.64-3.460.750759.125.28170,638.506.816.099.268.0632.4631.219.088.691.204.050.8544--5.562.3935.405.82-6.24--
Universal Health Services Inc16.08bn1.20bn11.89bn86.00k10.361.756.570.739317.8117.81239.04105.301.11--6.83187,024.108.436.6810.017.94----7.586.621.239.840.40315.6310.826.8259.177.047.565.92
Encompass Health Corp5.51bn494.00m12.02bn23.56k24.605.5512.462.184.844.8253.9921.440.8565--8.87233,941.6010.206.7213.268.3995.6095.4111.919.53--7.090.45726.0411.913.1326.024.949.72-10.27
Molina Healthcare Inc41.87bn1.18bn12.99bn18.00k11.573.009.510.310220.7020.70737.0879.812.62--12.242,325,889.007.377.3015.4415.9615.2215.662.812.86--12.810.46630.0019.3119.298.079.8511.90--
Tenet Healthcare Corp20.52bn1.46bn15.93bn74.48k11.343.815.030.776315.1215.12212.6045.010.70589.816.66275,510.208.096.3211.888.9882.3382.7511.468.841.706.080.60350.000.56942.26423.73--6.80--
Centene Corp169.28bn3.45bn16.58bn60.50k4.960.59373.530.09796.726.72329.5556.112.00--8.622,798,083.004.072.796.934.4210.2711.272.041.48--5.260.39540.005.8916.9222.3220.13-2.48--
Quest Diagnostics Inc10.16bn892.00m19.75bn45.00k22.502.8613.751.947.867.8689.5061.870.682936.717.45225,733.306.188.967.1310.4033.1536.159.0512.551.316.810.454125.686.705.021.880.73171.226.90
Labcorp Holdings Inc13.18bn730.80m21.92bn70.00k30.202.6413.901.668.678.67156.3699.130.772119.735.88188,248.604.296.165.217.3327.8932.185.559.171.605.480.404--6.972.4096.73-1.964.13--
Natera Inc1.83bn-189.76m22.09bn4.42k--17.74--12.06-1.47-1.4714.289.121.1414.986.03413,878.80-11.86-30.60-15.01-38.8261.7951.43-10.36-40.613.74--0.0609--56.7541.2056.20--72.97--
Humana Inc120.26bn1.71bn28.93bn65.68k16.951.6310.440.240514.1414.14996.52147.082.38----1,831,029.003.626.19--------1.522.69--5.470.427515.1110.7012.66-51.51-14.92-4.8210.49
Data as of Jul 03 2025. Currency figures normalised to Quest Diagnostics Inc's reporting currency: US Dollar USD

Institutional shareholders

42.06%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202513.40m12.07%
BlackRock Fund Advisorsas of 31 Mar 20256.37m5.74%
T. Rowe Price Associates, Inc. (IM)as of 31 Mar 20255.82m5.24%
SSgA Funds Management, Inc.as of 31 Mar 20255.18m4.67%
JPMorgan Investment Management, Inc.as of 31 Mar 20253.31m2.99%
Victory Capital Management, Inc. (Investment Management)as of 31 Mar 20253.13m2.82%
Geode Capital Management LLCas of 31 Mar 20252.77m2.50%
Davis Selected Advisers LPas of 31 Mar 20252.39m2.15%
Boston Partners Global Investors, Inc.as of 31 Mar 20252.30m2.07%
Grantham, Mayo, Van Otterloo & Co. LLCas of 31 Mar 20252.01m1.81%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.